When researchers treated GC-C knockout mice with amphetamine-based ADHD medication and an activator of the protein kinase PKG, they reversed the mice’s hyperactive, inattentive behavior.
The study was conducted by the Gastroenterology, Hepatology and Nutrition Department at Cincinnati Children’s Hospital Medical Center and scientists in China.
Read the Cincinnati Children’s Hospital release on linking guanylyl cyclase-C to ADHD.
Related Articles on Intestinal Conditions:
Treatment Uses Parasitic Worms to Fight Crohn’s Disease
Study: P53, PUMA Independently Regulate IEC Apoptosis in Colitis
Study: Probiotic-Derived Protein can Protect Intestinal Cells From Inflammation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
